BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Møller HJ. Soluble CD163. Scandinavian Journal of Clinical and Laboratory Investigation 2011;72:1-13. [DOI: 10.3109/00365513.2011.626868] [Cited by in Crossref: 218] [Cited by in F6Publishing: 212] [Article Influence: 19.8] [Reference Citation Analysis]
Number Citing Articles
1 Bhattacharya S, Yadav A, Aggarwal A. Evidence for M2 macrophage activation in patients with enthesitis-related arthritis category of juvenile idiopathic arthritis. Clin Rheumatol 2019;38:1715-9. [PMID: 30734215 DOI: 10.1007/s10067-018-04408-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Ye H, Wang LY, Zhao J, Wang K. Increased CD163 expression is associated with acute-on-chronic hepatitis B liver failure. World J Gastroenterol 2013; 19(18): 2818-2825 [PMID: 23687420 DOI: 10.3748/wjg.v19.i18.2818] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
3 Laursen TL, Wong GL, Kazankov K, Sandahl T, Møller HJ, Hamilton-dutoit S, George J, Chan HL, Grønbaek H. Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment: sCD163 and sMR in chronic hepatitis B. Journal of Gastroenterology and Hepatology 2018;33:484-91. [DOI: 10.1111/jgh.13849] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
4 Eichendorff S, Svendsen P, Bender D, Keiding S, Christensen EI, Deleuran B, Moestrup SK. Biodistribution and PET imaging of a novel [68Ga]-anti-CD163-antibody conjugate in rats with collagen-induced arthritis and in controls. Mol Imaging Biol 2015;17:87-93. [PMID: 25053229 DOI: 10.1007/s11307-014-0768-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
5 Gorin JB, Malone DFG, Strunz B, Carlsson T, Aleman S, Björkström NK, Falconer K, Sandberg JK. Plasma FABP4 is associated with liver disease recovery during treatment-induced clearance of chronic HCV infection. Sci Rep 2020;10:2081. [PMID: 32034167 DOI: 10.1038/s41598-020-58768-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
6 Kjærgaard AG, Rødgaard-Hansen S, Dige A, Krog J, Møller HJ, Tønnesen E. Monocyte expression and soluble levels of the haemoglobin receptor (CD163/sCD163) and the mannose receptor (MR/sMR) in septic and critically ill non-septic ICU patients. PLoS One 2014;9:e92331. [PMID: 24637679 DOI: 10.1371/journal.pone.0092331] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
7 Glavind E, Aagaard NK, Grønbæk H, Møller HJ, Orntoft NW, Vilstrup H, Thomsen KL. Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis. PLoS One 2016;11:e0158388. [PMID: 27379798 DOI: 10.1371/journal.pone.0158388] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
8 Anzinger JJ, Butterfield TR, Angelovich TA, Crowe SM, Palmer CS. Monocytes as regulators of inflammation and HIV-related comorbidities during cART. J Immunol Res 2014;2014:569819. [PMID: 25025081 DOI: 10.1155/2014/569819] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 6.6] [Reference Citation Analysis]
9 Zambuzi FA, Cardoso-Silva PM, Espindola MS, Soares LS, Galvão-Lima LJ, Brauer VS, Gomes MS, Amaral LR, Schaller M, Bollela VR, Frantz FG. Identification of promising plasma immune biomarkers to differentiate active pulmonary tuberculosis. Cytokine 2016;88:99-107. [PMID: 27591510 DOI: 10.1016/j.cyto.2016.08.030] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
10 Knudsen A, Møller HJ, Katzenstein TL, Gerstoft J, Obel N, Kronborg G, Benfield T, Kjaer A, Lebech AM. Soluble CD163 does not predict first-time myocardial infarction in patients infected with human immunodeficiency virus: a nested case-control study. BMC Infect Dis 2013;13:230. [PMID: 23692821 DOI: 10.1186/1471-2334-13-230] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
11 Vendrell J, Chacón MR. TWEAK: A New Player in Obesity and Diabetes. Front Immunol 2013;4:488. [PMID: 24416031 DOI: 10.3389/fimmu.2013.00488] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
12 Jung JY, Suh CH, Kim HA. The role of damage-associated molecular pattern for pathogenesis and biomarkers in adult-onset Still's disease. Expert Rev Mol Diagn 2019;19:459-68. [PMID: 31055973 DOI: 10.1080/14737159.2019.1615449] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
13 Naimi RM, Hvistendahl M, Nerup N, Ambrus R, Achiam MP, Svendsen LB, Grønbæk H, Møller HJ, Vilstrup H, Steensberg A, Jeppesen PB. Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trial. EBioMedicine 2019;46:444-51. [PMID: 31326433 DOI: 10.1016/j.ebiom.2019.07.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
14 Liang H, Duan Z, Li D, Li D, Wang Z, Ren L, Shen T, Shao Y. Higher levels of circulating monocyte-platelet aggregates are correlated with viremia and increased sCD163 levels in HIV-1 infection. Cell Mol Immunol 2015;12:435-43. [PMID: 25109683 DOI: 10.1038/cmi.2014.66] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
15 ten Oever J, Netea MG, Kullberg BJ. Utility of immune response-derived biomarkers in the differential diagnosis of inflammatory disorders. J Infect 2016;72:1-18. [PMID: 26429736 DOI: 10.1016/j.jinf.2015.09.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
16 Benki-Nugent SF, Martopullo I, Laboso T, Tamasha N, Wamalwa DC, Tapia K, Langat A, Maleche-Obimbo E, Marra CM, Bangirana P, Boivin MJ, John-Stewart GC. High Plasma Soluble CD163 During Infancy Is a Marker for Neurocognitive Outcomes in Early-Treated HIV-Infected Children. J Acquir Immune Defic Syndr 2019;81:102-9. [PMID: 30768490 DOI: 10.1097/QAI.0000000000001979] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
17 Krijgsman D, De Vries NL, Andersen MN, Skovbo A, Tollenaar RAEM, Møller HJ, Hokland M, Kuppen PJK. CD163 as a Biomarker in Colorectal Cancer: The Expression on Circulating Monocytes and Tumor-Associated Macrophages, and the Soluble Form in the Blood. Int J Mol Sci 2020;21:E5925. [PMID: 32824692 DOI: 10.3390/ijms21165925] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Schönbauer R, Lichtenauer M, Paar V, Emich M, Fritzer-Szekeres M, Schukro C, Strametz-Juranek J, Sponder M. Regular Training Increases sTWEAK and Its Decoy Receptor sCD163-Does Training Trigger the sTWEAK/sCD163-Axis to Induce an Anti-Inflammatory Effect? J Clin Med 2020;9:E1899. [PMID: 32560548 DOI: 10.3390/jcm9061899] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Liu X, Xia W, Zhang X, Xia X, Sun H. Fusion expression of the two soluble viral receptors of porcine reproductive and respiratory syndrome virus with a single adeno-associated virus vector. Res Vet Sci 2021;135:78-84. [PMID: 33453552 DOI: 10.1016/j.rvsc.2020.12.026] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Graversen JH, Moestrup SK. Drug Trafficking into Macrophages via the Endocytotic Receptor CD163. Membranes (Basel) 2015;5:228-52. [PMID: 26111002 DOI: 10.3390/membranes5020228] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
21 Rosso C, Kazankov K, Younes R, Esmaili S, Marietti M, Sacco M, Carli F, Gaggini M, Salomone F, Møller HJ, Abate ML, Vilstrup H, Gastaldelli A, George J, Grønbæk H, Bugianesi E. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease. Journal of Hepatology 2019;71:1012-21. [DOI: 10.1016/j.jhep.2019.06.031] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 17.3] [Reference Citation Analysis]
22 Czaja AJ. Under-Evaluated or Unassessed Pathogenic Pathways in Autoimmune Hepatitis and Implications for Future Management. Dig Dis Sci 2018;63:1706-25. [DOI: 10.1007/s10620-018-5072-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
23 Dige A, Støy S, Thomsen KL, Hvas CL, Agnholt J, Dahlerup JF, Møller HJ, Grønbaek H. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease. Scand J Immunol 2014;80:417-23. [PMID: 25346048 DOI: 10.1111/sji.12222] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
24 Kračmerová J, Rossmeislová L, Kováčová Z, Klimčáková E, Polák J, Tencerová M, Mališová L, Štich V, Langin D, Šiklová M. Soluble CD163 is associated with CD163 mRNA expression in adipose tissue and with insulin sensitivity in steady-state condition but not in response to calorie restriction. J Clin Endocrinol Metab 2014;99:E528-35. [PMID: 24423341 DOI: 10.1210/jc.2013-3348] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
25 Glavind E, Gotthardt DN, Pfeiffenberger J, Sandahl TD, Bashlekova T, Willemoe GL, Hasselby JP, Weiss KH, Møller HJ, Vilstrup H, Lee WM, Schilsky ML, Ott P, Grønbæk H. The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson's disease. Orphanet J Rare Dis 2020;15:173. [PMID: 32615997 DOI: 10.1186/s13023-020-01452-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Hønge BL, Andersen MN, Jespersen S, Medina C, Correira FG, Jakobsen MR, Laursen A, Erikstrup C, Møller HJ, Wejse C; Bissau HIV cohort study group. Brief Report: Macrophage Activation in HIV-2-Infected Patients Is Less Affected by Antiretroviral Treatment-sCD163 in HIV-1, HIV-2, and HIV-1/2 Dually Infected Patients. J Acquir Immune Defic Syndr 2016;72:254-8. [PMID: 26825178 DOI: 10.1097/QAI.0000000000000939] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
27 O'Reilly VP, Wong L, Kennedy C, Elliot LA, O'Meachair S, Coughlan AM, O'Brien EC, Ryan MM, Sandoval D, Connolly E, Dekkema GJ, Lau J, Abdulahad WH, Sanders JS, Heeringa P, Buckley C, O'Brien C, Finn S, Cohen CD, Lindemeyer MT, Hickey FB, O'Hara PV, Feighery C, Moran SM, Mellotte G, Clarkson MR, Dorman AJ, Murray PT, Little MA. Urinary Soluble CD163 in Active Renal Vasculitis. J Am Soc Nephrol 2016;27:2906-16. [PMID: 26940094 DOI: 10.1681/ASN.2015050511] [Cited by in Crossref: 54] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
28 Burdo TH, Weiffenbach A, Woods SP, Letendre S, Ellis RJ, Williams KC. Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection. AIDS 2013;27:1387-95. [PMID: 23435298 DOI: 10.1097/QAD.0b013e32836010bd] [Cited by in Crossref: 170] [Cited by in F6Publishing: 137] [Article Influence: 18.9] [Reference Citation Analysis]
29 Møller LN, Knudsen AR, Andersen KJ, Nyengaard JR, Hamilton-Dutoit S, Okholm Møller EM, Svendsen P, Møller HJ, Moestrup SK, Graversen JH, Mortensen FV. Anti-CD163-dexamethasone protects against apoptosis after ischemia/reperfusion injuries in the rat liver. Ann Med Surg (Lond) 2015;4:331-7. [PMID: 26566435 DOI: 10.1016/j.amsu.2015.09.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
30 Periyalil HA, Gibson PG, Wood LG. Immunometabolism in obese asthmatics: are we there yet? Nutrients 2013;5:3506-30. [PMID: 24025484 DOI: 10.3390/nu5093506] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
31 Cantero-Navarro E, Rayego-Mateos S, Orejudo M, Tejedor-Santamaria L, Tejera-Muñoz A, Sanz AB, Marquez-Exposito L, Marchant V, Santos-Sanchez L, Egido J, Ortiz A, Bellon T, Rodrigues-Diez RR, Ruiz-Ortega M. Role of Macrophages and Related Cytokines in Kidney Disease. Front Med (Lausanne) 2021;8:688060. [PMID: 34307414 DOI: 10.3389/fmed.2021.688060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Melin EO, Dereke J, Hillman M. Female sex, high soluble CD163, and low HDL-cholesterol were associated with high galectin-3 binding protein in type 1 diabetes. Biol Sex Differ 2019;10:51. [PMID: 31752995 DOI: 10.1186/s13293-019-0268-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
33 Shoji H, Yoshio S, Mano Y, Kumagai E, Sugiyama M, Korenaga M, Arai T, Itokawa N, Atsukawa M, Aikata H, Hyogo H, Chayama K, Ohashi T, Ito K, Yoneda M, Nozaki Y, Kawaguchi T, Torimura T, Abe M, Hiasa Y, Fukai M, Kamiyama T, Taketomi A, Mizokami M, Kanto T. Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease. Sci Rep 2016;6:28814. [PMID: 27363523 DOI: 10.1038/srep28814] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
34 Fathy M, Okabe M, M Othman E, Saad Eldien HM, Yoshida T. Preconditioning of Adipose-Derived Mesenchymal Stem-Like Cells with Eugenol Potentiates Their Migration and Proliferation In Vitro and Therapeutic Abilities in Rat Hepatic Fibrosis. Molecules 2020;25:E2020. [PMID: 32357508 DOI: 10.3390/molecules25092020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
35 Rødgaard-Hansen S, Rafique A, Christensen PA, Maniecki MB, Sandahl TD, Nexø E, Møller HJ. A soluble form of the macrophage-related mannose receptor (MR/CD206) is present in human serum and elevated in critical illness. Clin Chem Lab Med 2014;52:453-61. [PMID: 24114918 DOI: 10.1515/cclm-2013-0451] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 6.5] [Reference Citation Analysis]
36 Skytthe MK, Graversen JH, Moestrup SK. Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases. Int J Mol Sci 2020;21:E5497. [PMID: 32752088 DOI: 10.3390/ijms21155497] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
37 Vakili S, Fischer T, Rappaport J. M2 differentiation of MonoMac‐1 cell line induced by M‐CSF and glucocorticoid pathways. J Cell Physiol 2020;235:7383-91. [DOI: 10.1002/jcp.29638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Zingaropoli MA, Nijhawan P, Carraro A, Pasculli P, Zuccalà P, Perri V, Marocco R, Kertusha B, Siccardi G, Del Borgo C, Curtolo A, Ajassa C, Iannetta M, Ciardi MR, Mastroianni CM, Lichtner M. Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia. Front Immunol 2021;12:627548. [PMID: 33777012 DOI: 10.3389/fimmu.2021.627548] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
39 Niemelä O. Biomarker-Based Approaches for Assessing Alcohol Use Disorders. Int J Environ Res Public Health 2016;13:166. [PMID: 26828506 DOI: 10.3390/ijerph13020166] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 8.8] [Reference Citation Analysis]
40 Nissen SK, Shrivastava K, Schulte C, Otzen DE, Goldeck D, Berg D, Møller HJ, Maetzler W, Romero-Ramos M. Alterations in Blood Monocyte Functions in Parkinson's Disease. Mov Disord 2019;34:1711-21. [PMID: 31449711 DOI: 10.1002/mds.27815] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
41 Robicsek SA, Bhattacharya A, Rabai F, Shukla K, Doré S. Blood-Related Toxicity after Traumatic Brain Injury: Potential Targets for Neuroprotection. Mol Neurobiol 2020;57:159-78. [PMID: 31617072 DOI: 10.1007/s12035-019-01766-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
42 Kraaijvanger R, Janssen Bonás M, Vorselaars ADM, Veltkamp M. Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects. Front Immunol 2020;11:1443. [PMID: 32760396 DOI: 10.3389/fimmu.2020.01443] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
43 Niemelä M, Niemelä O, Bloigu R, Bloigu A, Kangastupa P, Juvonen T. Serum Calprotectin, a Marker of Neutrophil Activation, and Other Mediators of Inflammation in Response to Various Types of Extreme Physical Exertion in Healthy Volunteers. J Inflamm Res 2020;13:223-31. [PMID: 32547154 DOI: 10.2147/JIR.S250675] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
44 Peng Q, Zhang Y, Shu X, Yang H, Zhang L, Chen F, Lu X, Wang G. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue. J Rheumatol 2015;42:979-87. [DOI: 10.3899/jrheum.141307] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
45 Detzen L, Chen SCY, Cheng B, Papapanou PN, Lalla E. Increased levels of soluble CD163 in periodontitis patients. J Clin Periodontol 2017;44:585-90. [DOI: 10.1111/jcpe.12731] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
46 Melin EO, Dereke J, Thunander M, Hillman M. Soluble CD163 was linked to galectin-3, diabetic retinopathy and antidepressants in type 1 diabetes. Endocr Connect 2018;7:1343-53. [PMID: 30400063 DOI: 10.1530/EC-18-0336] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
47 Carrico AW, Cherenack EM, Roach ME, Riley ED, Oni O, Dilworth SE, Shoptaw S, Hunt P, Roy S, Pallikkuth S, Pahwa S. Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection. AIDS 2018;32:767-71. [PMID: 29369159 DOI: 10.1097/QAD.0000000000001751] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
48 Suraweera DB, Weeratunga AN, Hu RW, Pandol SJ, Hu R. Alcoholic hepatitis: The pivotal role of Kupffer cells. World J Gastrointest Pathophysiol 2015; 6(4): 90-98 [PMID: 26600966 DOI: 10.4291/wjgp.v6.i4.90] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
49 van der Zalm IJB, van der Valk ES, Wester VL, Nagtzaam NMA, van Rossum EFC, Leenen PJM, Dik WA. Obesity-associated T-cell and macrophage activation improve partly after a lifestyle intervention. Int J Obes (Lond) 2020;44:1838-50. [PMID: 32678324 DOI: 10.1038/s41366-020-0615-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
50 Samuelsson M, Dereke J, Svensson MK, Landin-Olsson M, Hillman M; on the behalf of the DISS Study group. Soluble plasma proteins ST2 and CD163 as early biomarkers of nephropathy in Swedish patients with diabetes, 15-34 years of age: a prospective cohort study. Diabetol Metab Syndr 2017;9:41. [PMID: 28559931 DOI: 10.1186/s13098-017-0240-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
51 Hisert KB, Birkland TP, Schoenfelt KQ, Long ME, Grogan B, Carter S, Liles WC, McKone EF, Becker L, Manicone AM, Gharib SA. CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis. Front Pharmacol 2020;11:1219. [PMID: 33013356 DOI: 10.3389/fphar.2020.01219] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
52 Semnani-Azad Z, Blanco Mejia S, Connelly PW, Bazinet RP, Retnakaran R, Jenkins DJA, Harris SB, Hanley AJ. The association of soluble CD163, a novel biomarker of macrophage activation, with type 2 diabetes mellitus and its underlying physiological disorders: A systematic review. Obes Rev 2021;22:e13257. [PMID: 33913230 DOI: 10.1111/obr.13257] [Reference Citation Analysis]
53 Benedetti S, Gemma Nasoni M, Palma F, Citarella R, Luchetti F. Serum changes in sTWEAK and its scavenger receptor sCD163 in ultramarathon athletes running the 24-h race. Cytokine 2021;137:155315. [PMID: 33011401 DOI: 10.1016/j.cyto.2020.155315] [Reference Citation Analysis]
54 Svart M, Rittig N, Møller N, Møller HJ, Gronbaek H. Soluble CD163 correlates with lipid metabolic adaptations in type 1 diabetes patients during ketoacidosis. J Diabetes Investig 2019;10:67-72. [PMID: 29802679 DOI: 10.1111/jdi.12869] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
55 Grønbæk H, Rødgaard-Hansen S, Aagaard NK, Arroyo V, Moestrup SK, Garcia E, Solà E, Domenicali M, Piano S, Vilstrup H, Møller HJ; CANONIC study investigators of the EASL-CLIF Consortium. Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF). J Hepatol 2016;64:813-22. [PMID: 26639396 DOI: 10.1016/j.jhep.2015.11.021] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 9.3] [Reference Citation Analysis]
56 Wang J, Yao Y, Xiong J, Wu J, Tang X, Li G. Evaluation of the inflammatory response in macrophages stimulated with exosomes secreted by Mycobacterium avium-infected macrophages. Biomed Res Int 2015;2015:658421. [PMID: 25861639 DOI: 10.1155/2015/658421] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
57 Bossen L, Vesterhus M, Hov JR, Färkkilä M, Rosenberg WM, Møller HJ, Boberg KM, Karlsen TH, Grønbæk H. Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis. Clin Transl Gastroenterol 2021;12:e00315. [PMID: 33646203 DOI: 10.14309/ctg.0000000000000315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Niemelä M, Kangastupa P, Niemelä O, Bloigu R, Juvonen T. Acute Changes in Inflammatory Biomarker Levels in Recreational Runners Participating in a Marathon or Half-Marathon. Sports Med Open 2016;2:21. [PMID: 27747777 DOI: 10.1186/s40798-016-0045-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
59 Kazankov K, Tordjman J, Møller HJ, Vilstrup H, Poitou C, Bedossa P, Bouillot JL, Clement K, Grønbaek H. Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery. J Gastroenterol Hepatol 2015;30:1293-300. [PMID: 25772748 DOI: 10.1111/jgh.12943] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
60 Sánchez-Carvajal JM, Rodríguez-Gómez IM, Ruedas-Torres I, Larenas-Muñoz F, Díaz I, Revilla C, Mateu E, Domínguez J, Martín-Valls G, Barranco I, Pallarés FJ, Carrasco L, Gómez-Laguna J. Activation of pro- and anti-inflammatory responses in lung tissue injury during the acute phase of PRRSV-1 infection with the virulent strain Lena. Vet Microbiol 2020;246:108744. [PMID: 32605751 DOI: 10.1016/j.vetmic.2020.108744] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
61 Ingels C, Møller HJ, Hansen TK, Wouters PJ, Vanhorebeek I, Van den Berghe G. Circulating levels of the shed scavenger receptor sCD163 and association with outcome of critically ill patients. J Clin Immunol. 2013;33:619-629. [PMID: 23150181 DOI: 10.1007/s10875-012-9830-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
62 Kawarabayashi R, Motoyama K, Nakamura M, Yamazaki Y, Morioka T, Mori K, Fukumoto S, Imanishi Y, Shioi A, Shoji T, Emoto M, Inaba M. The Association between Monocyte Surface CD163 and Insulin Resistance in Patients with Type 2 Diabetes. J Diabetes Res 2017;2017:6549242. [PMID: 29445750 DOI: 10.1155/2017/6549242] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
63 Sandahl TD, Grønbæk H, Møller HJ, Støy S, Thomsen KL, Dige AK, Agnholt J, Hamilton-dutoit S, Thiel S, Vilstrup H. Hepatic Macrophage Activation and the LPS Pathway in Patients With Alcoholic Hepatitis: A Prospective Cohort Study. American Journal of Gastroenterology 2014;109:1749-56. [DOI: 10.1038/ajg.2014.262] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 7.6] [Reference Citation Analysis]
64 Ajami B, Steinman L. Nonclassical monocytes: are they the next therapeutic targets in multiple sclerosis? Immunol Cell Biol 2018;96:125-7. [PMID: 29352485 DOI: 10.1111/imcb.12004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
65 Garton T, Keep RF, Hua Y, Xi G. Brain iron overload following intracranial haemorrhage. Stroke Vasc Neurol 2016;1:172-84. [PMID: 28959481 DOI: 10.1136/svn-2016-000042] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 9.0] [Reference Citation Analysis]
66 Sepiashvili L, Alli Z, Bohn MK, Hall A, Karin A, Murata K, Adeli K. Complex biological patterns of soluble cytokines and CD163 in childhood necessitating age-specific reference intervals for evidence-based clinical interpretation. Clin Biochem 2021:S0009-9120(21)00245-9. [PMID: 34509468 DOI: 10.1016/j.clinbiochem.2021.09.004] [Reference Citation Analysis]
67 Imp BM, Rubin LH, Tien PC, Plankey MW, Golub ET, French AL, Valcour VG. Monocyte Activation Is Associated With Worse Cognitive Performance in HIV-Infected Women With Virologic Suppression. J Infect Dis 2017;215:114-21. [PMID: 27789726 DOI: 10.1093/infdis/jiw506] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 9.2] [Reference Citation Analysis]
68 Siggaard CB, Kazankov K, Rødgaard-Hansen S, Møller HJ, Donnelly MC, Simpson KJ, Grønbaek H. Macrophage markers soluble CD163 and soluble mannose receptor are associated with liver injury in patients with paracetamol overdose. Scand J Gastroenterol 2019;54:623-32. [PMID: 31067143 DOI: 10.1080/00365521.2019.1608292] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
69 Nivukoski U, Bloigu A, Bloigu R, Kultti J, Tuomi H, Niemelä O. Comparison of serum calprotectin, a marker of neutrophil activation, and other mediators of inflammation in response to alcohol consumption. Alcohol 2021;95:45-50. [PMID: 34228990 DOI: 10.1016/j.alcohol.2021.06.001] [Reference Citation Analysis]
70 Mascia C, Lichtner M, Zuccalà P, Vita S, Tieghi T, Marocco R, Savinelli S, Rossi R, Iannetta M, Campagna M, Schiavone F, Mengoni F, Russo G, Mastroianni CM, Vullo V. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection. Clinics and Research in Hepatology and Gastroenterology 2017;41:644-55. [DOI: 10.1016/j.clinre.2017.04.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
71 Thomsen JH, Etzerodt A, Svendsen P, Moestrup SK. The haptoglobin-CD163-heme oxygenase-1 pathway for hemoglobin scavenging. Oxid Med Cell Longev. 2013;2013:523652. [PMID: 23781295 DOI: 10.1155/2013/523652] [Cited by in Crossref: 92] [Cited by in F6Publishing: 91] [Article Influence: 10.2] [Reference Citation Analysis]
72 Rødgaard-hansen S, St. George A, Kazankov K, Bauman A, George J, Grønbæk H, Jon Møller H. Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease. Scandinavian Journal of Clinical and Laboratory Investigation 2017;77:498-504. [DOI: 10.1080/00365513.2017.1346823] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
73 El Aggan H, Mahmoud S, El Shair H, Elabd H. Increased macrophage activation marker soluble CD163 is associated with graft dysfunction and metabolic derangements in renal transplant recipients. Biomedical Journal 2020. [DOI: 10.1016/j.bj.2020.09.004] [Reference Citation Analysis]
74 Møller HJ, Tesar V, Little MA. Urine sCD163: a window onto glomerular inflammation. Nephrol Dial Transplant 2016;31:1970-2. [DOI: 10.1093/ndt/gfw257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
75 Tornai T, Vitalis Z, Sipeki N, Dinya T, Tornai D, Antal-Szalmas P, Karanyi Z, Tornai I, Papp M. Macrophage activation marker, soluble CD163 is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection. Liver Int. 2016; Epub ahead of print. [PMID: 27031405 DOI: 10.1111/liv.13133] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
76 O’halloran JA, Satchell CS, Mallon PW. Dyslipidemia, atherosclerosis and cardiovascular disease: an increasingly important triad in an aging population living with HIV. Future Virology 2013;8:1021-34. [DOI: 10.2217/fvl.13.87] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
77 Dultz G, Gerber L, Zeuzem S, Sarrazin C, Waidmann O. The macrophage activation marker CD163 is associated with IL28B genotype and hepatic inflammation in chronic hepatitis C virus infected patients. J Viral Hepat. 2016;23:267-273. [PMID: 26554542 DOI: 10.1111/jvh.12488] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
78 Bossen L, Rebora P, Bernuzzi F, Jepsen P, Gerussi A, Andreone P, Galli A, Terziroli B, Alvaro D, Labbadia G, Aloise C, Baiocchi L, Giannini E, Abenavoli L, Toniutto P, Marra F, Marzioni M, Niro G, Floreani A, Møller HJ, Valsecchi MG, Carbone M, Grønbaek H, Invernizzi P. Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis. Liver Int 2020;40:1408-14. [PMID: 32279422 DOI: 10.1111/liv.14466] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
79 Vajavaara H, Ekeblad F, Holte H, Jorgensen J, Leivonen SK, Berglund M, Kamper P, Moller HJ, D'Amore F, Molin D, Enblad G, Ludvigsen M, Glimelius I, Leppa S. Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma. Haematologica 2021;106:2502-6. [PMID: 33764002 DOI: 10.3324/haematol.2020.278182] [Reference Citation Analysis]
80 Novakovic P, Harding JC, Ladinig A, Al-Dissi AN, MacPhee DJ, Detmer SE. Relationships of CD163 and CD169 positive cell numbers in the endometrium and fetal placenta with type 2 PRRSV RNA concentration in fetal thymus. Vet Res 2016;47:76. [PMID: 27494990 DOI: 10.1186/s13567-016-0364-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
81 McGuire JL, Gill AJ, Douglas SD, Kolson DL; CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) group. Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders. J Neurovirol 2015;21:439-48. [PMID: 25776526 DOI: 10.1007/s13365-015-0333-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 54] [Article Influence: 6.4] [Reference Citation Analysis]
82 Andersen MN, Andersen NF, Rødgaard-hansen S, Hokland M, Abildgaard N, Møller HJ. The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): Implications in multiple myeloma. Leukemia Research 2015;39:971-5. [DOI: 10.1016/j.leukres.2015.06.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
83 Kühl AA, Erben U, Kredel LI, Siegmund B. Diversity of Intestinal Macrophages in Inflammatory Bowel Diseases. Front Immunol 2015;6:613. [PMID: 26697009 DOI: 10.3389/fimmu.2015.00613] [Cited by in Crossref: 87] [Cited by in F6Publishing: 88] [Article Influence: 12.4] [Reference Citation Analysis]
84 Benki-Nugent S, Boivin MJ. Neurocognitive Complications of Pediatric HIV Infections. Curr Top Behav Neurosci 2021;50:147-74. [PMID: 31522375 DOI: 10.1007/7854_2019_102] [Reference Citation Analysis]
85 Guo Y, Ren M, Ge L, Sun C, Li R, Ma C, Sui S. Increased Serum Concentrations of TNF-Like Weak Inducer of Apoptosis Predict Higher 28-Day Mortality in Patients with Sepsis. Emerg Med Int 2019;2019:7238705. [PMID: 30733876 DOI: 10.1155/2019/7238705] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Brock C, Brock B, Pedersen AG, Drewes AM, Jessen N, Farmer AD. Assessment of the cardiovascular and gastrointestinal autonomic complications of diabetes. World J Diabetes 2016; 7(16): 321-332 [PMID: 27625746 DOI: 10.4239/wjd.v7.i16.321] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
87 Adly AAM, Ismail EAR, Ibraheem TM. Macrophage-derived soluble CD163 level in young patients with Gaucher disease: relation to phenotypes, disease severity and complications. Int Immunopharmacol 2015;24:416-22. [PMID: 25587690 DOI: 10.1016/j.intimp.2014.12.039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
88 Björklund J, Laursen TL, Sandahl TD, Møller HJ, Vilstrup H, Ott P, Grønbæk H. High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study. Orphanet J Rare Dis 2018;13:169. [PMID: 30241550 DOI: 10.1186/s13023-018-0910-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
89 Kazankov K, Rode A, Simonsen K, Villadsen GE, Nicoll A, Møller HJ, Lim L, Angus P, Kronborg I, Arachchi N, Gorelik A, Liew D, Vilstrup H, Frystyk J, Grønbæk H. Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma. Scand J Clin Lab Invest 2016;76:64-73. [PMID: 26549495 DOI: 10.3109/00365513.2015.1099722] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
90 Kimer N, Gudmann NS, Pedersen JS, Møller S, Nielsen MJ, Leeming DJ, Karsdal MA, Møller HJ, Bendtsen F, Grønbæk H. No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial. PLoS One 2018;13:e0203200. [PMID: 30183743 DOI: 10.1371/journal.pone.0203200] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
91 Liu H, Lin D, Xiang H, Chen W, Zhao S, Peng H, Yang J, Chen P, Chen S, Lu H. The role of tumor necrosis factor-like weak inducer of apoptosis in atherosclerosis via its two different receptors. Exp Ther Med 2017;14:891-7. [PMID: 28781615 DOI: 10.3892/etm.2017.4600] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
92 Moran SM, Scott J, Clarkson MR, Conlon N, Dunne J, Griffin MD, Griffin TP, Groarke E, Holian J, Judge C, Wyse J, McLoughlin K, O'Hara PV, Little MA, Kretzler M; Nephrotic Syndrome Study Network (NEPTUNE). The Clinical Application of Urine Soluble CD163 in ANCA-Associated Vasculitis. J Am Soc Nephrol 2021;32:2920-32. [PMID: 34518279 DOI: 10.1681/ASN.2021030382] [Reference Citation Analysis]
93 Simón-muela I, Llauradó G, Chacón MR, Olona M, Näf S, Maymó-masip E, Gil P, de la Flor M, Gonzalez Clemente JM, Vendrell J, Megía A. Reduced circulating levels of TWEAK are associated with Gestational Diabetes Mellitus. Eur J Clin Invest 2015;45:27-35. [DOI: 10.1111/eci.12375] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
94 Sipeki N, Antal-Szalmas P, Lakatos PL, Papp M. Immune dysfunction in cirrhosis. World J Gastroenterol 2014; 20(10): 2564-2577 [PMID: 24627592 DOI: 10.3748/wjg.v20.i10.2564] [Cited by in CrossRef: 97] [Cited by in F6Publishing: 78] [Article Influence: 12.1] [Reference Citation Analysis]
95 Waidmann O, Brunner F, Herrmann E, Zeuzem S, Piiper A, Kronenberger B. Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis. Journal of Hepatology 2013;58:956-61. [DOI: 10.1016/j.jhep.2013.01.005] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 8.2] [Reference Citation Analysis]
96 Walker JA, Sulciner ML, Nowicki KD, Miller AD, Burdo TH, Williams KC. Elevated numbers of CD163+ macrophages in hearts of simian immunodeficiency virus-infected monkeys correlate with cardiac pathology and fibrosis. AIDS Res Hum Retroviruses 2014;30:685-94. [PMID: 24524407 DOI: 10.1089/AID.2013.0268] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
97 Fjeldborg K, Christiansen T, Bennetzen M, J Møller H, Pedersen SB, Richelsen B. The macrophage-specific serum marker, soluble CD163, is increased in obesity and reduced after dietary-induced weight loss. Obesity (Silver Spring) 2013;21:2437-43. [PMID: 23512476 DOI: 10.1002/oby.20376] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 6.3] [Reference Citation Analysis]
98 Glezeva N, Voon V, Watson C, Horgan S, Mcdonald K, Ledwidge M, Baugh J. Exaggerated Inflammation and Monocytosis Associate With Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction: Evidence of M2 Macrophage Activation in Disease Pathogenesis. Journal of Cardiac Failure 2015;21:167-77. [DOI: 10.1016/j.cardfail.2014.11.004] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 9.7] [Reference Citation Analysis]
99 Kirkegaard-Klitbo DM, Mejer N, Knudsen TB, Møller HJ, Moestrup SK, Poulsen SD, Kronborg G, Benfield T. Soluble CD163 predicts incident chronic lung, kidney and liver disease in HIV infection. AIDS 2017;31:981-8. [PMID: 28252527 DOI: 10.1097/QAD.0000000000001432] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
100 Newell E, Shellington DK, Simon DW, Bell MJ, Kochanek PM, Feldman K, Bayir H, Aneja RK, Carcillo JA, Clark RS. Cerebrospinal Fluid Markers of Macrophage and Lymphocyte Activation After Traumatic Brain Injury in Children. Pediatr Crit Care Med 2015;16:549-57. [PMID: 25850867 DOI: 10.1097/PCC.0000000000000400] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
101 Kazankov K, Bojsen-Møller KN, Møller HJ, Madsbad S, Grønbaek H. Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux-en-Y gastric bypass. Physiol Rep 2022;10:e15157. [PMID: 35040267 DOI: 10.14814/phy2.15157] [Reference Citation Analysis]
102 Gjelstrup MC, Stilund M, Petersen T, Møller HJ, Petersen EL, Christensen T. Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis. Immunol Cell Biol 2018;96:160-74. [PMID: 29363161 DOI: 10.1111/imcb.1025] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 7.4] [Reference Citation Analysis]
103 Shimamoto Y, Nio-kobayashi J, Watarai H, Nagano M, Saito N, Takahashi E, Higuchi H, Kobayashi A, Kimura T, Kitamura H. Generation and validation of novel anti-bovine CD163 monoclonal antibodies ABM-1A9 and ABM-2D6. Veterinary Immunology and Immunopathology 2018;198:6-13. [DOI: 10.1016/j.vetimm.2018.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
104 Laursen TL, Sandahl TD, Kazankov K, Eriksen PL, Kristensen LH, Holmboe CH, Laursen AL, Vilstrup H, Grønbæk H. Early normalization of reduced urea synthesis capacity after direct-acting antiviral therapy in hepatitis C cirrhosis. Am J Physiol Gastrointest Liver Physiol 2020;319:G151-6. [PMID: 32597708 DOI: 10.1152/ajpgi.00128.2020] [Reference Citation Analysis]
105 Muñoz-Nevárez LA, Imp BM, Eller MA, Kiweewa F, Maswai J, Polyak C, Olwenyi OA, Allen IE, Rono E, Milanini B, Kibuuka H, Ake JA, Eller LA, Valcour VG. Monocyte activation, HIV, and cognitive performance in East Africa. J Neurovirol 2020;26:52-9. [PMID: 31468471 DOI: 10.1007/s13365-019-00794-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
106 Hattori A, Takemoto M, Tokuyama H, Koshizaka M, Yokote K. Sitagliptin but not alpha glucosidase inhibitor reduced the serum soluble CD163, a marker for activated macrophage, in individuals with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 2017;126:138-43. [DOI: 10.1016/j.diabres.2017.02.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
107 Al-Quraishy SA, Dkhil MA, Abdel-Baki AA, Delic D, Wunderlich F. Protective Vaccination against Blood-Stage Malaria of Plasmodium chabaudi: Differential Gene Expression in the Liver of Balb/c Mice toward the End of Crisis Phase. Front Microbiol 2016;7:1087. [PMID: 27471498 DOI: 10.3389/fmicb.2016.01087] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
108 Nascimento GG, Møller HJ, López R. Macrophage activity is associated with gingival inflammation: Soluble CD163 in an experimental gingivitis study. Cytokine 2020;127:154954. [PMID: 31918162 DOI: 10.1016/j.cyto.2019.154954] [Reference Citation Analysis]
109 Bari MF, Weickert MO, Sivakumar K, James SG, Snead DR, Tan BK, Randeva HS, Bastie CC, Vatish M. Elevated soluble CD163 in gestational diabetes mellitus: secretion from human placenta and adipose tissue. PLoS One 2014;9:e101327. [PMID: 24983948 DOI: 10.1371/journal.pone.0101327] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
110 Generoso M, Álvarez P, Kravietz A, Mwamzuka M, Marshed F, Ahmed A, Khaitan A. High soluble CD163 levels correlate with disease progression and inflammation in Kenyan children with perinatal HIV-infection. AIDS 2020;34:33-8. [PMID: 31567161 DOI: 10.1097/QAD.0000000000002378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 El-Guindy DM, Elgarhy LH, Elkholy RA, Ali DA, Helal DS. Potential role of tumor-associated macrophages and CD163/CD68 ratio in mycosis fungoides and Sézary syndrome in correlation with serum sCD163 and CCL22. J Cutan Pathol 2021. [PMID: 34687561 DOI: 10.1111/cup.14155] [Reference Citation Analysis]
112 Scully EP, Lockhart A, Garcia-Beltran W, Palmer CD, Musante C, Rosenberg E, Allen TM, Chang JJ, Bosch RJ, Altfeld M. Innate immune reconstitution with suppression of HIV-1. JCI Insight 2016;1:e85433. [PMID: 27158667 DOI: 10.1172/jci.insight.85433] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
113 Burdo TH, Lackner A, Williams KC. Monocyte/macrophages and their role in HIV neuropathogenesis. Immunol Rev 2013;254:102-13. [PMID: 23772617 DOI: 10.1111/imr.12068] [Cited by in Crossref: 128] [Cited by in F6Publishing: 121] [Article Influence: 16.0] [Reference Citation Analysis]
114 Yadav VR, Hussain A, Xie J, Kosanke S, Awasthi V. The salutary effects of diphenyldifluoroketone EF24 in liver of a rat hemorrhagic shock model. Scand J Trauma Resusc Emerg Med 2015;23:8. [PMID: 25645333 DOI: 10.1186/s13049-015-0098-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
115 Kobayashi Y, Yoshida S, Nakama T, Zhou Y, Ishikawa K, Arita R, Nakao S, Miyazaki M, Sassa Y, Oshima Y, Izuhara K, Kono T, Ishibashi T. Overexpression of CD163 in vitreous and fibrovascular membranes of patients with proliferative diabetic retinopathy: possible involvement of periostin. Br J Ophthalmol 2015;99:451-6. [PMID: 25281471 DOI: 10.1136/bjophthalmol-2014-305321] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
116 Czaja AJ. Emerging therapeutic biomarkers of autoimmune hepatitis and their impact on current and future management. Expert Rev Gastroenterol Hepatol 2018;12:547-64. [PMID: 29540068 DOI: 10.1080/17474124.2018.1453356] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
117 Monnig MA, Cohen R, Ramratnam B, McAdams M, Tashima K, Monti PM. HIV Infection, HCV Coinfection, and Alcohol Use: Associations with Microbial Translocation and Immune Activation. Alcohol Clin Exp Res 2019;43:1126-34. [PMID: 30908642 DOI: 10.1111/acer.14032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
118 Al-Daghri NM, Al-Attas OS, Bindahman LS, Alokail MS, Alkharfy KM, Draz HM, Yakout S, McTernan PG, Sabico S, Chrousos GP. Soluble CD163 is associated with body mass index and blood pressure in hypertensive obese Saudi patients. Eur J Clin Invest 2012;42:1221-6. [PMID: 22946776 DOI: 10.1111/j.1365-2362.2012.02714.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
119 Etzerodt A, Kjolby M, Nielsen MJ, Maniecki M, Svendsen P, Moestrup SK. Plasma clearance of hemoglobin and haptoglobin in mice and effect of CD163 gene targeting disruption. Antioxid Redox Signal 2013;18:2254-63. [PMID: 22793784 DOI: 10.1089/ars.2012.4605] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 5.4] [Reference Citation Analysis]
120 Gusev E, Sarapultsev A, Hu D, Chereshnev V. Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes). Int J Mol Sci 2021;22:7582. [PMID: 34299201 DOI: 10.3390/ijms22147582] [Reference Citation Analysis]
121 Melin EO, Svensson R, Dereke J, Hillman M. Galectin-3 Binding Protein, Depression, and Younger Age Were Independently Associated With Alexithymia in Adult Patients With Type 1 Diabetes. Front Psychiatry 2021;12:672931. [PMID: 34045984 DOI: 10.3389/fpsyt.2021.672931] [Reference Citation Analysis]
122 Kumar NP, Moideen K, Bhootra Y, Nancy A, Viswanathan V, Shruthi BS, Sivakumar S, Natarajan M, Kornfeld H, Babu S. Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co-morbidity. Immunology 2019;156:249-58. [PMID: 30427060 DOI: 10.1111/imm.13023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
123 Etzerodt A, Moestrup SK. CD163 and inflammation: biological, diagnostic, and therapeutic aspects. Antioxid Redox Signal. 2013;18:2352-2363. [PMID: 22900885 DOI: 10.1089/ars.2012.4834] [Cited by in Crossref: 218] [Cited by in F6Publishing: 214] [Article Influence: 21.8] [Reference Citation Analysis]
124 Pranzatelli MR, Tate ED, McGee NR. Microglial/macrophage markers CHI3L1, sCD14, and sCD163 in CSF and serum of pediatric inflammatory and non-inflammatory neurological disorders: A case-control study and reference ranges. J Neurol Sci 2017;381:285-90. [PMID: 28991699 DOI: 10.1016/j.jns.2017.09.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
125 Costa-Hurtado M, Olvera A, Martinez-Moliner V, Galofré-Milà N, Martínez P, Dominguez J, Aragon V. Changes in macrophage phenotype after infection of pigs with Haemophilus parasuis strains with different levels of virulence. Infect Immun 2013;81:2327-33. [PMID: 23589574 DOI: 10.1128/IAI.00056-13] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
126 Scriven JE, Rhein J, Hullsiek KH, von Hohenberg M, Linder G, Rolfes MA, Williams DA, Taseera K, Meya DB, Meintjes G, Boulware DR; COAT Team. Early ART After Cryptococcal Meningitis Is Associated With Cerebrospinal Fluid Pleocytosis and Macrophage Activation in a Multisite Randomized Trial. J Infect Dis 2015;212:769-78. [PMID: 25651842 DOI: 10.1093/infdis/jiv067] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.9] [Reference Citation Analysis]
127 Chua CL, Brown GV, Hamilton JA, Molyneux ME, Rogerson SJ, Boeuf P. Soluble CD163, a product of monocyte/macrophage activation, is inversely associated with haemoglobin levels in placental malaria. PLoS One 2013;8:e64127. [PMID: 23717548 DOI: 10.1371/journal.pone.0064127] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
128 Nishino A, Katsumata Y, Kawasumi H, Hirahara S, Kawaguchi Y, Yamanaka H. Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus. Lupus 2019;28:986-94. [PMID: 31246559 DOI: 10.1177/0961203319860201] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
129 Rusu CC, Racasan S, Kacso IM, Ghervan L, Moldovan D, Potra A, Patiu IM, Bondor C, Caprioara MG. The association of high sCD163/sTWEAK ratio with cardiovascular disease in hemodialysis patients. Int Urol Nephrol 2015;47:2023-30. [PMID: 26433887 DOI: 10.1007/s11255-015-1114-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
130 Stilund M, Gjelstrup MC, Petersen T, Møller HJ, Rasmussen PV, Christensen T. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel. PLoS One 2015;10:e0119681. [PMID: 25860354 DOI: 10.1371/journal.pone.0119681] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
131 Gantzel RH, Kjær MB, Laursen TL, Kazankov K, George J, Møller HJ, Grønbæk H. Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis. Front Med (Lausanne) 2020;7:615599. [PMID: 33490096 DOI: 10.3389/fmed.2020.615599] [Reference Citation Analysis]
132 Kazankov K, Barrera F, Møller HJ, Rosso C, Bugianesi E, David E, Younes R, Esmaili S, Eslam M, McLeod D, Bibby BM, Vilstrup H, George J, Grønbaek H. The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease. Liver Int 2016;36:1549-57. [PMID: 27102725 DOI: 10.1111/liv.13150] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 10.2] [Reference Citation Analysis]
133 Lim R, Lappas M, Riley C, Borregaard N, Moller HJ, Ahmed N, Rice GE. Investigation of human cationic antimicrobial protein-18 (hCAP-18), lactoferrin and CD163 as potential biomarkers for ovarian cancer. J Ovarian Res 2013;6:5. [PMID: 23339669 DOI: 10.1186/1757-2215-6-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
134 Murphy VE, Jensen ME, Powell H, Gibson PG. Influence of Maternal Body Mass Index and Macrophage Activation on Asthma Exacerbations in Pregnancy. J Allergy Clin Immunol Pract 2017;5:981-987.e1. [PMID: 28552381 DOI: 10.1016/j.jaip.2017.03.040] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
135 Thomsen KL, Robertson FP, Holland-Fischer P, Davidson BR, Mookerjee RP, Møller HJ, Jalan R, Grønbæk H. The Macrophage Activation Marker Soluble CD163 is Associated With Early Allograft Dysfunction After Liver Transplantation. J Clin Exp Hepatol 2019;9:302-11. [PMID: 31360022 DOI: 10.1016/j.jceh.2018.09.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
136 Nielsen MC, Hvidbjerg Gantzel R, Clària J, Trebicka J, Møller HJ, Grønbæk H. Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure. Cells 2020;9:E1175. [PMID: 32397365 DOI: 10.3390/cells9051175] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
137 Kazankov K, Alisi A, Møller HJ, De Vito R, Rittig S, Mahler B, Nobili V, Grønbæk H. Macrophage Markers Are Poorly Associated With Liver Histology in Children With Nonalcoholic Fatty Liver Disease. J Pediatr Gastroenterol Nutr 2018;67:635-42. [PMID: 30074574 DOI: 10.1097/MPG.0000000000002111] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
138 Ruiz-Plazas X, Rodríguez-Gallego E, Alves M, Altuna-Coy A, Lozano-Bartolomé J, Portero-Otin M, García-Fontgivell JF, Martínez-González S, Segarra J, Chacón MR. Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness. J Transl Med 2019;17:307. [PMID: 31500625 DOI: 10.1186/s12967-019-2053-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
139 Stilund M, Gjelstrup MC, Christensen T, Møller HJ, Petersen T. A multi-biomarker follow-up study of patients with multiple sclerosis. Brain Behav 2016;6:e00509. [PMID: 27688939 DOI: 10.1002/brb3.509] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
140 Kyriazopoulou E, Giamarellos-Bourboulis EJ. Monitoring immunomodulation in patients with sepsis. Expert Rev Mol Diagn 2021;21:17-29. [PMID: 33183116 DOI: 10.1080/14737159.2020.1851199] [Reference Citation Analysis]
141 Semnani-Azad Z, Connelly PW, Johnston LW, Retnakaran R, Harris SB, Zinman B, Hanley AJ. The Macrophage Activation Marker Soluble CD163 is Longitudinally Associated With Insulin Sensitivity and β-cell Function. J Clin Endocrinol Metab 2020;105:dgz166. [PMID: 31677389 DOI: 10.1210/clinem/dgz166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
142 Colafrancesco S, Priori R, Alessandri C, Astorri E, Perricone C, Blank M, Agmon-Levin N, Shoenfeld Y, Valesini G. sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia. Immunol Res 2014;60:177-83. [PMID: 25388964 DOI: 10.1007/s12026-014-8563-7] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 6.9] [Reference Citation Analysis]
143 Tejedor-santamaria L, Morgado-pascual JL, Marquez-exposito L, Suarez-alvarez B, Rodrigues-diez RR, Tejera-muñoz A, Marchant V, Mezzano S, Lopez-larrea C, Sola A, Fernandez-juarez GM, Ortiz A, Rayego-mateos S, Ruiz-ortega M. Epigenetic Modulation of Gremlin-1/NOTCH Pathway in Experimental Crescentic Immune-Mediated Glomerulonephritis. Pharmaceuticals 2022;15:121. [DOI: 10.3390/ph15020121] [Reference Citation Analysis]
144 Grønbaek H, Kreutzfeldt M, Kazankov K, Jessen N, Sandahl T, Hamilton-dutoit S, Vilstrup H, J. Møller H. Single-centre experience of the macrophage activation marker soluble (s)CD163 - associations with disease activity and treatment response in patients with autoimmune hepatitis. Aliment Pharmacol Ther 2016;44:1062-70. [DOI: 10.1111/apt.13801] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
145 Gao M, Wei Y, Xu Q, Ji R, Han Z, Jiang T. Elevated serum YKL-40 correlates with clinical characteristics in patients with polymyositis or dermatomyositis. Ann Clin Biochem 2019;56:95-9. [DOI: 10.1177/0004563218786979] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
146 Trancă S, Oever JT, Ciuce C, Netea M, Slavcovici A, Petrișor C, Hagău N. sTREM-1, sIL-2Rα, and IL-6, but not sCD163, might predict sepsis in polytrauma patients: a prospective cohort study. Eur J Trauma Emerg Surg 2017;43:363-70. [PMID: 27169526 DOI: 10.1007/s00068-016-0678-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
147 Micci L, Alvarez X, Iriele RI, Ortiz AM, Ryan ES, McGary CS, Deleage C, McAtee BB, He T, Apetrei C, Easley K, Pahwa S, Collman RG, Derdeyn CA, Davenport MP, Estes JD, Silvestri G, Lackner AA, Paiardini M. CD4 depletion in SIV-infected macaques results in macrophage and microglia infection with rapid turnover of infected cells. PLoS Pathog 2014;10:e1004467. [PMID: 25356757 DOI: 10.1371/journal.ppat.1004467] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 9.8] [Reference Citation Analysis]
148 Lambrecht J, Tacke F. Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease. Front Immunol 2020;11:634409. [PMID: 33633748 DOI: 10.3389/fimmu.2020.634409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
149 Stilund M, Reuschlein AK, Christensen T, Møller HJ, Rasmussen PV, Petersen T. Soluble CD163 as a marker of macrophage activity in newly diagnosed patients with multiple sclerosis. PLoS One 2014;9:e98588. [PMID: 24886843 DOI: 10.1371/journal.pone.0098588] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 4.8] [Reference Citation Analysis]
150 Knudsen TB, Ertner G, Petersen J, Møller HJ, Moestrup SK, Eugen-Olsen J, Kronborg G, Benfield T. Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals. J Infect Dis 2016;214:1198-204. [PMID: 27354366 DOI: 10.1093/infdis/jiw263] [Cited by in Crossref: 70] [Cited by in F6Publishing: 75] [Article Influence: 11.7] [Reference Citation Analysis]
151 Kvorning SL, Nielsen MC, Andersen NF, Hokland M, Andersen MN, Møller HJ. Circulating extracellular vesicle-associated CD163 and CD206 in multiple myeloma. Eur J Haematol 2020;104:409-19. [PMID: 31855290 DOI: 10.1111/ejh.13371] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
152 Guo L, Harari E, Virmani R, Finn AV. Linking Hemorrhage, Angiogenesis, Macrophages, and Iron Metabolism in Atherosclerotic Vascular Diseases. ATVB 2017;37. [DOI: 10.1161/atvbaha.117.309045] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
153 Mitrovic S, Fautrel B. New Markers for Adult-Onset Still's Disease. Joint Bone Spine 2018;85:285-93. [DOI: 10.1016/j.jbspin.2017.05.011] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
154 Dultz G, Gerber L, Farnik H, Berger A, Vermehren J, Pleli T, Zeuzem S, Piiper A, Kronenberger B, Waidmann O. Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus. J Viral Hepat 2015;22:427-32. [DOI: 10.1111/jvh.12309] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
155 Zhang J, Song L, Pedersen DV, Li A, Lambris JD, Andersen GR, Mollnes TE, Ma YJ, Garred P. Soluble collectin-12 mediates C3-independent docking of properdin that activates the alternative pathway of complement. Elife 2020;9:e60908. [PMID: 32909942 DOI: 10.7554/eLife.60908] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
156 Molvin J, Jujić A, Melander O, Pareek M, Råstam L, Lindblad U, Daka B, Leósdóttir M, Nilsson PM, Olsen MH, Magnusson M. Proteomic exploration of common pathophysiological pathways in diabetes and cardiovascular disease. ESC Heart Fail 2020. [PMID: 33047884 DOI: 10.1002/ehf2.13036] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
157 Alonso I, Matos A, Ribeiro R, Gil Â, Cardoso C, Sardinha LB, Bicho M. Mountain Cycling Ultramarathon Effects on Inflammatory and Hemoglobin Responses. Med Sci Sports Exerc 2018;50:353-60. [PMID: 28991044 DOI: 10.1249/MSS.0000000000001440] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
158 Mosepele M, Hemphill LC, Moloi W, Moyo S, Nkele I, Makhema J, Bennett K, Triant VA, Lockman S. Pre-clinical carotid atherosclerosis and sCD163 among virally suppressed HIV patients in Botswana compared with uninfected controls. PLoS One 2017;12:e0179994. [PMID: 28662159 DOI: 10.1371/journal.pone.0179994] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
159 Akahori H, Karmali V, Polavarapu R, Lyle AN, Weiss D, Shin E, Husain A, Naqvi N, Van Dam R, Habib A, Choi CU, King AL, Pachura K, Taylor WR, Lefer DJ, Finn AV. CD163 interacts with TWEAK to regulate tissue regeneration after ischaemic injury. Nat Commun 2015;6:7792. [PMID: 26242746 DOI: 10.1038/ncomms8792] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 7.1] [Reference Citation Analysis]
160 Persidsky Y. Insights into end-organ injury in HIV infection: dynamics of monocyte trafficking to the brain in SIV encephalitis. Am J Pathol 2015;185:1548-51. [PMID: 25963553 DOI: 10.1016/j.ajpath.2015.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
161 Norton DL, Ceppe A, Tune MK, McCravy M, Devlin T, Drummond MB, Carson SS, Vincent BG, Hagan RS, Dang H, Doerschuk CM, Mock JR. Bronchoalveolar Tregs are associated with duration of mechanical ventilation in acute respiratory distress syndrome. J Transl Med 2020;18:427. [PMID: 33176790 DOI: 10.1186/s12967-020-02595-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
162 Gallego-Durán R, Montero-Vallejo R, Maya-Miles D, Lucena A, Martin F, Ampuero J, Romero-Gómez M. Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases. Front Immunol 2021;12:667354. [PMID: 34899679 DOI: 10.3389/fimmu.2021.667354] [Reference Citation Analysis]
163 Mascia C, Vita S, Zuccalà P, Marocco R, Tieghi T, Savinelli S, Rossi R, Iannetta M, Pozzetto I, Furlan C, Mengoni F, Mastroianni CM, Vullo V, Lichtner M. Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon. PLoS One 2017;12:e0179400. [PMID: 28636655 DOI: 10.1371/journal.pone.0179400] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
164 Ørntoft NW, Blé M, Baiges A, Ferrusquia J, Hernández-Gea V, Turon F, Magaz M, Møller S, Møller HJ, Garcia-Pagan JC, Gronbaek H. Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension. Front Physiol 2021;12:649668. [PMID: 34177608 DOI: 10.3389/fphys.2021.649668] [Reference Citation Analysis]
165 De Fino C, Lucchini M, Lucchetti D, Nociti V, Losavio F, Bianco A, Colella F, Ricciardi-tenore C, Sgambato A, Mirabella M. The predictive value of CSF multiple assay in multiple sclerosis: A single center experience. Multiple Sclerosis and Related Disorders 2019;35:176-81. [DOI: 10.1016/j.msard.2019.07.030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
166 Schram AM, Berliner N. How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood. 2015;125:2908-2914. [PMID: 25758828 DOI: 10.1182/blood-2015-01-551622] [Cited by in Crossref: 165] [Cited by in F6Publishing: 148] [Article Influence: 23.6] [Reference Citation Analysis]
167 Waidmann O, Köberle V, Bettinger D, Trojan J, Zeuzem S, Schultheiß M, Kronenberger B, Piiper A. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma. J Hepatol. 2013;59:769-779. [PMID: 23792028 DOI: 10.1016/j.jhep.2013.06.008] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 5.6] [Reference Citation Analysis]
168 Etzerodt A, Rasmussen MR, Svendsen P, Chalaris A, Schwarz J, Galea I, Møller HJ, Moestrup SK. Structural basis for inflammation-driven shedding of CD163 ectodomain and tumor necrosis factor-α in macrophages. J Biol Chem 2014;289:778-88. [PMID: 24275664 DOI: 10.1074/jbc.M113.520213] [Cited by in Crossref: 55] [Cited by in F6Publishing: 37] [Article Influence: 6.1] [Reference Citation Analysis]
169 Merino KM, Allers C, Didier ES, Kuroda MJ. Role of Monocyte/Macrophages during HIV/SIV Infection in Adult and Pediatric Acquired Immune Deficiency Syndrome. Front Immunol 2017;8:1693. [PMID: 29259605 DOI: 10.3389/fimmu.2017.01693] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
170 Ma YJ, Hein E, Munthe-fog L, Skjoedt M, Bayarri-olmos R, Romani L, Garred P. Soluble Collectin-12 (CL-12) Is a Pattern Recognition Molecule Initiating Complement Activation via the Alternative Pathway. J I 2015;195:3365-73. [DOI: 10.4049/jimmunol.1500493] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
171 Colafrancesco S, Priori R, Valesini G. Presentation and diagnosis of adult-onset Still’s disease: the implications of current and emerging markers in overcoming the diagnostic challenge. Expert Review of Clinical Immunology 2015;11:749-61. [DOI: 10.1586/1744666x.2015.1037287] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 3.4] [Reference Citation Analysis]
172 Thomsen HH, Møller HJ, Trolle C, Groth KA, Skakkebæk A, Bojesen A, Høst C, Gravholt CH. The macrophage low-grade inflammation marker sCD163 is modulated by exogenous sex steroids. Endocr Connect 2013;2:216-24. [PMID: 24148221 DOI: 10.1530/EC-13-0067] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
173 Tebas P, Spitsin S, Barrett JS, Tuluc F, Elci O, Korelitz JJ, Wagner W, Winters A, Kim D, Catalano R, Evans DL, Douglas SD. Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults. AIDS 2015;29:931-9. [PMID: 25915168 DOI: 10.1097/QAD.0000000000000638] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
174 Gutiérrez-Muñoz C, Méndez-Barbero N, Svendsen P, Sastre C, Fernández-Laso V, Quesada P, Egido J, Escolá-Gil JC, Martín-Ventura JL, Moestrup SK, Blanco-Colio LM. CD163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice. FASEB J 2020;34:14960-76. [PMID: 32924185 DOI: 10.1096/fj.202000177R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
175 Pallikkuth S, Bolivar H, Fletcher MA, Babic DZ, De Armas LR, Gupta S, Termini JM, Arheart KL, Stevenson M, Tung FY, Fischl MA, Pahwa S, Stone GW. A therapeutic HIV-1 vaccine reduces markers of systemic immune activation and latent infection in patients under highly active antiretroviral therapy. Vaccine 2020;38:4336-45. [PMID: 32387010 DOI: 10.1016/j.vaccine.2020.04.015] [Reference Citation Analysis]
176 Periyalil HA, Wood LG, Scott HA, Jensen ME, Gibson PG. Macrophage activation, age and sex effects of immunometabolism in obese asthma. Eur Respir J 2015;45:388-95. [PMID: 25186264 DOI: 10.1183/09031936.00080514] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
177 Fitzpatrick ME, Nouraie M, Gingo MR, Camp D, Kessinger CJ, Sincebaugh JB, Clarke A, Ries JW, Kleerup EC, Kingsley L, Morris A. Novel relationships of markers of monocyte activation and endothelial dysfunction with pulmonary dysfunction in HIV-infected persons. AIDS 2016;30:1327-39. [PMID: 26990629 DOI: 10.1097/QAD.0000000000001092] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 6.4] [Reference Citation Analysis]
178 Deichgræber P, Witte DR, Møller HJ, Skriver MV, Richelsen B, Jørgensen ME, Johansen NB, Sandbæk A. Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohort. Diabetologia 2016;59:2467-76. [PMID: 27541014 DOI: 10.1007/s00125-016-4075-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
179 Moran SM, Monach PA, Zgaga L, Cuthbertson D, Carette S, Khalidi NA, Koening CL, Langford CA, McAlear CA, Moreland L, Pagnoux C, Seo P, Specks U, Sreih A, Wyse J, Ytterberg SR, Merkel PA, Little MA; Vasculitis Clinical Research Consortium. Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrol Dial Transplant 2020;35:283-91. [PMID: 30380100 DOI: 10.1093/ndt/gfy300] [Cited by in Crossref: 14] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
180 Eljaszewicz A, Kleina K, Grubczak K, Radzikowska U, Zembko P, Kaczmarczyk P, Tynecka M, Dworzanczyk K, Naumnik B, Moniuszko M. Elevated Numbers of Circulating Very Small Embryonic-Like Stem Cells (VSELs) and Intermediate CD14++CD16+ Monocytes in IgA Nephropathy. Stem Cell Rev Rep 2018;14:686-93. [PMID: 30022351 DOI: 10.1007/s12015-018-9840-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
181 Xie WJ, Yu HQ, Zhang Y, Liu Q, Meng HM. CD163 promotes hematoma absorption and improves neurological functions in patients with intracerebral hemorrhage. Neural Regen Res 2016;11:1122-7. [PMID: 27630696 DOI: 10.4103/1673-5374.187047] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
182 Højen JF, Rasmussen TA, Andersen KL, Winckelmann AA, Laursen RR, Gunst JD, Møller HJ, Fujita M, Østergaard L, Søgaard OS, Dinarello CA, Tolstrup M. Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir. Mol Med 2015;21:337-45. [PMID: 25879630 DOI: 10.2119/molmed.2015.00031] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
183 Nederby L, Roug AS, Knudsen SS, Skovbo A, Kjeldsen E, Moller HJ, Hokland M. Soluble CD163 as a prognostic biomarker in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 2015;56:3219-21. [PMID: 25747973 DOI: 10.3109/10428194.2015.1026899] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
184 Andersen MN, Abildgaard N, Maniecki MB, Møller HJ, Andersen NF. Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma. Eur J Haematol 2014;93:41-7. [PMID: 24612259 DOI: 10.1111/ejh.12296] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 4.5] [Reference Citation Analysis]
185 Qian S, Zhang H, Dai H, Ma B, Tian F, Jiang P, Gao H, Sha X, Sun X. Is sCD163 a Clinical Significant Prognostic Value in Cancers? A Systematic Review and Meta-Analysis. Front Oncol 2020;10:585297. [PMID: 33240816 DOI: 10.3389/fonc.2020.585297] [Reference Citation Analysis]
186 Kallestrup M, Møller HJ, Tankisi H, Andersen H. Soluble CD163 levels are elevated in cerebrospinal fluid and serum in people with Type 2 diabetes mellitus and are associated with impaired peripheral nerve function. Diabet Med 2015;32:54-61. [PMID: 25156085 DOI: 10.1111/dme.12568] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
187 Nielsen AJ, Nielsen MC, Birn H, Ivarsen P, Møller HJ, Hviid CVB. Urine soluble CD163 (sCD163) as biomarker in glomerulonephritis: stability, reference interval and diagnostic performance. Clin Chem Lab Med 2020:cclm-2020-0466. [PMID: 33068375 DOI: 10.1515/cclm-2020-0466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
188 Feist E, Mitrovic S, Fautrel B. Mechanisms, biomarkers and targets for adult-onset Still's disease. Nat Rev Rheumatol 2018;14:603-18. [PMID: 30218025 DOI: 10.1038/s41584-018-0081-x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 81] [Article Influence: 29.3] [Reference Citation Analysis]
189 Boutet MA, Courties G, Nerviani A, Le Goff B, Apparailly F, Pitzalis C, Blanchard F. Novel insights into macrophage diversity in rheumatoid arthritis synovium. Autoimmun Rev 2021;20:102758. [PMID: 33476818 DOI: 10.1016/j.autrev.2021.102758] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
190 Moin ASM, Sathyapalan T, Butler AE, Atkin SL. Vitamin D Association With Macrophage-Derived Cytokines in Polycystic Ovary Syndrome: An Enhanced Risk of COVID-19 Infection? Front Endocrinol (Lausanne) 2021;12:638621. [PMID: 33716989 DOI: 10.3389/fendo.2021.638621] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
191 Furukoji E, Gi T, Yamashita A, Moriguchi-Goto S, Kojima M, Sugita C, Sakae T, Sato Y, Hirai T, Asada Y. CD163 macrophage and erythrocyte contents in aspirated deep vein thrombus are associated with the time after onset: a pilot study. Thromb J 2016;14:46. [PMID: 27895532 DOI: 10.1186/s12959-016-0122-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
192 Fourman LT, Czerwonka N, Shaikh SD, Stanley TL, Burdo TH, Williams KC, Fitch KV, Lo J, Grinspoon SK. Insulin-like growth factor 1 inversely relates to monocyte/macrophage activation markers in HIV. AIDS 2018;32:927-32. [PMID: 29424780 DOI: 10.1097/QAD.0000000000001775] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
193 Lee HJ, Ehlerding EB, Cai W. Antibody-Based Tracers for PET/SPECT Imaging of Chronic Inflammatory Diseases. Chembiochem 2019;20:422-36. [PMID: 30240550 DOI: 10.1002/cbic.201800429] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
194 Rødgaard-Hansen S, Rafique A, Weis N, Wejse C, Nielsen H, Pedersen SS, Møller HJ, Kronborg G. Increased concentrations of the soluble mannose receptor in serum from patients with pneumococcal bacteraemia, and prediction of survival. Infect Dis (Lond) 2015;47:203-8. [PMID: 25650730 DOI: 10.3109/00365548.2014.984321] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
195 Kazankov K, Barrera F, Møller HJ, Bibby BM, Vilstrup H, George J, Grønbaek H. Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C. Hepatology. 2014;60:521-530. [PMID: 24623375 DOI: 10.1002/hep.27129] [Cited by in Crossref: 102] [Cited by in F6Publishing: 102] [Article Influence: 12.8] [Reference Citation Analysis]
196 Bernatowicz PL, Golec P, Bielecki P, Kowal K. Systemic corticosteroid therapy augments ex vivo release of sCD163 by peripheral blood monocytes of asthmatic patients. Postepy Dermatol Alergol 2020;37:61-5. [PMID: 32467686 DOI: 10.5114/ada.2020.93384] [Reference Citation Analysis]
197 Noor MT, Manoria P. Immune Dysfunction in Cirrhosis. J Clin Transl Hepatol. 2017;5:50-58. [PMID: 28507927 DOI: 10.14218/jcth.2016.00056] [Cited by in Crossref: 10] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
198 Yadav A, Betts MR, Collman RG. Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders. J Neurovirol 2016;22:584-96. [PMID: 27021071 DOI: 10.1007/s13365-016-0433-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
199 Buisson A, Bringer MA, Barnich N, Vazeille E. Macrophages Versus Escherichia coli: A Decisive Fight in Crohn's Disease. Inflamm Bowel Dis 2016;22:2943-55. [PMID: 27824652 DOI: 10.1097/MIB.0000000000000946] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
200 Etzerodt A, Berg RM, Plovsing RR, Andersen MN, Bebien M, Habbeddine M, Lawrence T, Møller HJ, Moestrup SK. Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of 'soluble CD163' in plasma. Sci Rep 2017;7:40286. [PMID: 28084321 DOI: 10.1038/srep40286] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
201 Perricone C, Bartoloni E, Bursi R, Cafaro G, Guidelli GM, Shoenfeld Y, Gerli R. COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy. Immunol Res 2020;68:213-24. [PMID: 32681497 DOI: 10.1007/s12026-020-09145-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 18.5] [Reference Citation Analysis]
202 Nissen SK, Ferreira SA, Nielsen MC, Schulte C, Shrivastava K, Hennig D, Etzerodt A, Graversen JH, Berg D, Maetzler W, Panhelainen A, Møller HJ, Brockmann K, Romero-Ramos M. Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease. Mov Disord 2021;36:963-76. [PMID: 33332647 DOI: 10.1002/mds.28424] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
203 Tuluc F, Meshki J, Spitsin S, Douglas SD. HIV infection of macrophages is enhanced in the presence of increased expression of CD163 induced by substance P. J Leukoc Biol 2014;96:143-50. [PMID: 24577568 DOI: 10.1189/jlb.4AB0813-434RR] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
204 Kranaster L, Hoyer C, Mindt S, Neumaier M, Müller N, Zill P, Schwarz MJ, Moll N, Lutz B, Bindila L, Zerr I, Schmitz M, Blennow K, Zetterberg H, Haffner D, Leifheit-nestler M, Ozbalci C, Sartorius A. The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluid. Eur Arch Psychiatry Clin Neurosci 2020;270:911-9. [DOI: 10.1007/s00406-019-01086-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
205 Kazankov K, Rosso C, Younes R, Armandi A, Hagström H, Møller HJ, Stål P, Bugianesi E, Grønbæk H. Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease. Front Med (Lausanne) 2020;7:616212. [PMID: 33392234 DOI: 10.3389/fmed.2020.616212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
206 Cassius C, Le Buanec H, Bouaziz JD, Amode R. Biomarkers in Adult Dermatomyositis: Tools to Help the Diagnosis and Predict the Clinical Outcome. J Immunol Res 2019;2019:9141420. [PMID: 30766892 DOI: 10.1155/2019/9141420] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
207 Rubio-Navarro A, Carril M, Padro D, Guerrero-Hue M, Tarín C, Samaniego R, Cannata P, Cano A, Villalobos JM, Sevillano ÁM, Yuste C, Gutiérrez E, Praga M, Egido J, Moreno JA. CD163-Macrophages Are Involved in Rhabdomyolysis-Induced Kidney Injury and May Be Detected by MRI with Targeted Gold-Coated Iron Oxide Nanoparticles. Theranostics 2016;6:896-914. [PMID: 27162559 DOI: 10.7150/thno.14915] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
208 Karrasch T, Brünnler T, Hamer OW, Schmid K, Voelk M, Herfarth H, Buechler C. Soluble CD163 is increased in patients with acute pancreatitis independent of disease severity. Exp Mol Pathol 2015;99:236-9. [PMID: 26209500 DOI: 10.1016/j.yexmp.2015.07.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
209 Ljubenkov PA, Miller Z, Mumford P, Zhang J, Allen IE, Mitic L, Staffaroni A, Heuer H, Rojas JC, Cobigo Y, Karydas A, Pearlman R, Miller B, Kramer JH, McGrath MS, Rosen HJ, Boxer AL. Peripheral Innate Immune Activation Correlates With Disease Severity in GRN Haploinsufficiency. Front Neurol 2019;10:1004. [PMID: 31620075 DOI: 10.3389/fneur.2019.01004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
210 Yang G, Guo N, Yin J, Wu J. Elevated soluble CD163 predicts renal function deterioration in lupus nephritis: a cohort study in Eastern China. J Int Med Res 2021;49:3000605211049963. [PMID: 34755559 DOI: 10.1177/03000605211049963] [Reference Citation Analysis]
211 Zhang T, Li H, Vanarsa K, Gidley G, Mok CC, Petri M, Saxena R, Mohan C. Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages. Front Immunol 2020;11:671. [PMID: 32351512 DOI: 10.3389/fimmu.2020.00671] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
212 van Griensven J, Diro E, Lopez-Velez R, Ritmeijer K, Boelaert M, Zijlstra EE, Hailu A, Lynen L. A screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward? PLoS Negl Trop Dis 2014;8:e3011. [PMID: 25101627 DOI: 10.1371/journal.pntd.0003011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
213 Libraty DH, Wang P, Guo Z, Bigcas V, Brion JD, Capeding RZ. The Pattern of Adipose Tissue Accumulation during Early Infancy Provides an Environment for the Development of Dengue Hemorrhagic Fever. PLoS Negl Trop Dis 2015;9:e0004267. [PMID: 26636570 DOI: 10.1371/journal.pntd.0004267] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
214 Fjeldborg K, Pedersen SB, Møller HJ, Rask P, Danielsen AV, Stødkilde-jørgensen H, Richelsen B. Intrahepatic fat content correlates with soluble CD163 in relation to weight loss induced by Roux-en-Y gastric bypass: sCD163 in Relation to Fat Distribution and RYGB. Obesity 2015;23:154-61. [DOI: 10.1002/oby.20942] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
215 Heftdal LD, Loft AG, Hendricks O, Ashouri Christiansen A, Schiøttz-christensen B, Arnbak B, Jurik AG, Østgård R, Winding Deleuran B, Møller HJ, Greisen SR. Divergent effects on macrophage biomarkers soluble CD163 and CD206 in axial spondyloarthritis. Scandinavian Journal of Clinical and Laboratory Investigation 2018;78:483-9. [DOI: 10.1080/00365513.2018.1500704] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
216 Degroote H, Van Dierendonck A, Geerts A, Van Vlierberghe H, Devisscher L. Preclinical and Clinical Therapeutic Strategies Affecting Tumor-Associated Macrophages in Hepatocellular Carcinoma. J Immunol Res 2018;2018:7819520. [PMID: 30410942 DOI: 10.1155/2018/7819520] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]